Dacheng Biological has long-term strategic cooperation with many large enterprises at home and abroad in the domestic and international trade business of the original drug. It has the dual advantages of product category resources and price. Over the years, in addition to long-term commitment to serve many downstream customers in China, Strengthening sales in Southeast Asia, Eastern Europe, South America, Africa and other international markets, the annual trade volume of raw drugs reached 500 million yuan, and the product quality and service have been widely praised by customers. Dacheng Biotechnology hopes to cooperate sincerely with colleagues in the industry at home and abroad to achieve mutual benefit and win-win results.